Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Search
About Us
Sign in
Chemical Industry News, Data & Insights
About Us
Sign in
Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Products
WEEKLY
FOCUS
ALPHA
Project Updates and Milestones news
(page 3)
12 June 2026
Roche VENTANA PTEN (SP218) FDA-cleared as PTEN companion diagnostic in prostate cancer
First FDA-cleared IHC companion diagnostic to detect PTEN protein loss and select patients for capivasertib (TRUQAP) plus abiraterone therapy.
12 June 2026
Merck: FDA approves KEYTRUDA and KEYTRUDA QLEX with WELIREG for adjuvant ccRCC
FDA cleared PD‑1 plus HIF‑2α adjuvant regimens after Phase 3 showed 28% lower recurrence risk and 81% vs 74% 24‑month DFS; notable anemia, hypoxia and treatment discontinuations.
12 June 2026
BASF’s Tinosorb S (bemotrizinol) approved by FDA as first new U.S. sunscreen active in 27 years
FDA clears bemotrizinol, a broad‑spectrum, photostable UV filter that enables longer‑lasting, stronger UVA/UVB protection and improved formulation stability.
12 June 2026
GSK’s momelotinib gains orphan drug status in US and EU for VEXAS
Orphan designations back development of momelotinib for VEXAS; ATLAS phase II/III underway with design to be shown at EHA 2026.
12 June 2026
Sinopec and Inner Mongolia sign comprehensive strategic cooperation agreement
Regional government and state energy group agree to deepen project-level cooperation, align development plans and expand projects including hydrogen, carbon fiber and coal-chemicals.
11 June 2026
WuXi Biologics included in S&P Global Sustainability Yearbook (China) for fourth consecutive year
Placed in S&P Global CSA Global Top 1% and included in both the Global and China Sustainability Yearbooks; company emphasises Green CRDMO solutions.
The right choices in the European chemical industry
Save time with
chemXplore Alpha
Learn more
11 June 2026
Genmab: Epcoritamab plus R2 shows consistent benefit across EPCORE FL‑1 subgroups
Post‑hoc subgroup analysis of the Phase 3 EPCORE FL‑1 shows epcoritamab+rituximab+lenalidomide delivers consistent PFS, ORR and CRR gains with a manageable safety profile across risk and fitness subgroups.
11 June 2026
Novo Nordisk: Wegovy pill approved in UK as first daily GLP-1 weight-loss tablet in Europe
Daily 25 mg semaglutide tablet approved as adjunct to diet and exercise for adults with obesity or overweight plus a weight‑related condition; private prescriptions expected soon.
11 June 2026
SPIE Belgium to integrate 304 MWh battery park in Auvelais
304 MWh, 4‑hour storage to inject 76 MVA into the 150 kV grid; 82 Megapack containers; civil works to summer 2026 and commissioning end Jan 2027.
11 June 2026
Johnson & Johnson’s IMAAVY shows rapid, durable hemoglobin gains in Phase 2/3 wAIHA trial
Nipocalimab 30 mg/kg produced rapid hemoglobin rises and ~3× more durable responders versus placebo at 24 weeks, with early fatigue improvement and reduced steroid use.
11 June 2026
Takeda's zasocitinib outperforms deucravacitinib in Phase 3 psoriasis head-to-head
Once-daily oral TYK2 inhibitor showed statistical superiority to deucravacitinib for PASI100 and key secondary endpoints, with >35% achieving complete skin clearance at week 16.
11 June 2026
Exolum starts operations at Madeira Airport, to invest €4.5m+ in fuel facilities
Will expand storage to 1,300 m³, upgrade hydrant network and invest over €4.5m by 2029 under a 7‑year contract (option to 9).
11 June 2026
European Commission secures stronger MSR safeguards for ETS2 (buildings & road transport)
Strengthened MSR for ETS2 doubles allowance injections, extends reserve validity past 2030, enables earlier gradual releases, and starts early auctions in 2027 with a €3bn frontloading facility.
11 June 2026
Aurubis Hamburg opens high-capacity RDE exhaust and filter system
Expanded RDE system doubles diffuse-emission reduction to ~80%, treats >1.6M m3/hr, returns captured metals to production; part of a €115m programme with KfW backing.
11 June 2026
Air Liquide and ArianeGroup renew industrial partnership with two Ariane 6 contracts
Contracts cover cryogenic manufacturing equipment through flight 42 and a three‑year supply of propellants and ground gases for Ariane 6 operations.
11 June 2026
MOL concludes talks with Serbian government on NIS shareholders' agreement
Includes Pancevo refinery, retail network and E&P assets; supplies 80% of Serbia's fuel needs and has stations in Bosnia, Bulgaria and Romania; seller/authority talks continue.
10 June 2026
Genentech: FDA grants Priority Review for Tecentriq plus chemotherapy in stage III dMMR/MSI‑H colon cancer
FDA accepted an sBLA for adjuvant PD‑L1 therapy plus chemotherapy in stage III dMMR/MSI‑H colon cancer; agency decision expected Oct 9, 2026.
10 June 2026
Aptar N‑Sorb patent allowed by USPTO for packaging-based nitrosamine mitigation
USPTO allowed a patent for N‑Sorb, a packaging material that reduces nitrosamines across multiple APIs and may support FDA Orange Book strategies.
10 June 2026
EBN, Eni, Gasunie, OGE, Shell and TotalEnergies sign MoU on Delta Rhine Corridor CO₂ pipeline
Cross-border CO₂ pipeline to link North Rhine‑Westphalia industrial clusters to Dutch North Sea storage; target operation 2033 with initial Dutch sections in 2032.
10 June 2026
Worley completes FEED for Alfanar Lighthouse Green Fuels SAF plant
Engineering milestone clears path to FID end‑2027 and commercial operations in 2032; plant to produce 180 ML SAF and 30 ML renewable naphtha annually.
10 June 2026
dsm-firmenich: FDA approves bemotrizinol (PARSOL® Shield) for U.S. suncare
FDA clears bemotrizinol (PARSOL® Shield), the first new U.S. sunscreen active in 25+ years, enabling broad‑spectrum, photostable formulas with low‑concentration efficacy.
10 June 2026
DuPont: U.S. healthcare sites now on 100% renewable electricity
Twelve U.S. healthcare manufacturing sites matched to ~30,000 MWh annually via RECs, cutting Scope 2 emissions and supporting 2035 and 2050 climate targets.
10 June 2026
Evonik opens pilot plant for high-performance AEM membrane
Pilot-scale polymer membrane production for AEM electrolysis targets up to 2.5 GW/year, enabling lower-cost green hydrogen and manufactured without PFAS.
10 June 2026
H-Power signs deal to sell 5,000 kg green hydrogen from cracked ammonia to Protium
First UK commercial bulk sale of hydrogen from cracked ammonia; 5,000 kg of ISO 14687 Grade D (99.97%) green hydrogen; permit amended to allow third‑party sales.
10 June 2026
H-Power sells two LC30 fuel cell generators to TAMGO for Saudi trials
Two LC30 units will run hot-weather field trials in Saudi Arabia, then customer trials and GCC demonstrations; TAMGO will act as exclusive regional distributor.
10 June 2026
ARLANXEO and Covestro reduce Baypren GWP using ISCC PLUS chlorine
Switch to ISCC PLUS-certified chlorine lowers chloroprene rubber emissions; full conversion completed Jan 2026, ~20% GWP cut versus 2025; Eco grades add certified butadiene.
10 June 2026
Topsoe wins DKK 25m for PowerFactor to standardize Power‑to‑X grid integration
Grant-backed project will replace case-by-case grid studies with standardized methods, using electrolyzers, eREACT, SOEC and grid emulation at a Viborg pilot site.
10 June 2026
Air Liquide launches Cryocap FG pilot for cement CO₂ capture
3,000 Nm³/h Cryocap FG pilot at Holcim’s CaptureLab pre-treats and preconcentrates cement flue gas for CO₂ purification; modular and relocatable.
10 June 2026
Holcim launches CaptureLab carbon capture test platform
Industrial-scale, plug-and-play test platform in France for validating diverse carbon-capture technologies on real cement emissions.
9 June 2026
Moeve 2025 Environmental Statement for La Rábida and Palos
Annual report shows €33.8m+ invested in environmental upgrades, 100% renewable power in 2025, major waste recovery and water-use cuts, plus EU funding for green hydrogen project.
← Previous
Next →
